Adjei, A.L., Chaudhary, I., Kollins, S.H., Padilla, A. (2020). A pharmacokinetic study of methylphenidate hydrochloride multilayer extended-release capsules (Aptensio xr®) in preschool-aged children with attention-deficit/hyperactivity disorder.
Paediatr. Drugs, 22(5), 561-570.
[
http://dx.doi.org/10.1007/s40272-020-00409-z] [PMID:
32776159]
Ajabnoor, G.M.A., Bahijri, S., Shaik, N.A., Borai, A., Alamoudi, A.A., Al-Aama, J.Y., Chrousos, G.P. (2017). Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors.
PLoS One, 12(4), e0174342.
[
http://dx.doi.org/10.1371/journal.pone.0174342] [PMID:
28384165]
Akan, M., Unal, S., Gonenir Erbay, L., Taskapan, M.C. (2023). The effect of Ramadan fasting on mental health and some hormonal levels in healthy males.
Egypt. J. Neurol. Psychiat. Neurosurg., 59(1), 20.
[
http://dx.doi.org/10.1186/s41983-023-00623-9]
Akgül, S., Derman, O., Kanbur, N.Ö. (2014). Fasting during ramadan: A religious factor as a possible trigger or exacerbator for eating disorders in adolescents.
Int. J. Eat. Disord., 47(8), 905-910.
[
http://dx.doi.org/10.1002/eat.22255] [PMID:
24474707]
Akhtar, A.M., Ghouri, N., Chahal, C.A.A., Patel, R., Ricci, F., Sattar, N., Waqar, S., Khanji, M.Y. (2022). Ramadan fasting: Recommendations for patients with cardiovascular disease.
Heart, 108(4), 258-265.
[
http://dx.doi.org/10.1136/heartjnl-2021-319273] [PMID:
33990414]
Almai, A.M., Salpekar, J.A. (2023). Healthcare utilisation in the United Arab Emirates for children with attention-deficit hyperactivity disorder and comorbidities.
BJPsych Int., 20(3), 61-63.
[
http://dx.doi.org/10.1192/bji.2023.14] [PMID:
37531226]
Al-Rawi, N., Madkour, M., Jahrami, H., Salahat, D., Alhasan, F., BaHammam, A., Al-Islam Faris, M. (2020). Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: A prospective observational study.
PLoS One, 15(8), e0237922.
[
http://dx.doi.org/10.1371/journal.pone.0237922] [PMID:
32845924]
Al-Saedi, Z.S., Alharbi, A.M., Nmnkany, A.M., Alzubaidi, B.K., Alansari, A.N., Alhuzali, M., Shatla, M.M. (2023). Prevalence of attention deficit hyperactivity disorder among children in Makkah region, Saudi Arabia.
Cureus, 15(3), e35967.
[
http://dx.doi.org/10.7759/cureus.35967] [PMID:
37041915]
Auiler, J.F., Liu, K., Lynch, J.M., Gelotte, C.K. (2002). Effect of food on early drug exposure from extended-release stimulants: Results from the Concerta, Adderall XR Food Evaluation (CAFE) Study.
Curr. Med. Res. Opin., 18(5), 311-316.
[
http://dx.doi.org/10.1185/030079902125000840] [PMID:
12240794]
Aziz El-Sayed, A.A., Sabet, E.A. (2015). Fasting Ramadan in diabetic patients: When is fasting not advisable in a person with diabetes?
J. Pak. Med. Assoc., 65(5) (Suppl. 1), S22-S25.
[PMID:
26013778]
Becker, S.P., Epstein, J.N., Tamm, L., Tilford, A.A., Tischner, C.M., Isaacson, P.A., Simon, J.O., Beebe, D.W. (2019). Shortened sleep duration causes sleepiness, inattention, and oppositionality in adolescents with attention-deficit/hyperactivity disorder: Findings from a crossover sleep restriction/extension study.
J. Am. Acad. Child Adolesc. Psychiatry, 58(4), 433-442.
[
http://dx.doi.org/10.1016/j.jaac.2018.09.439] [PMID:
30768404]
Bener, A., Al Qahtani, R., Teebi, A.S., Bessisso, M. (2008). The prevalence of attention deficit hyperactivity symptoms in schoolchildren in a highly consanguineous community.
Med. Princ. Pract., 17(6), 440-446.
[
http://dx.doi.org/10.1159/000151564] [PMID:
18836271]
Biederman, J., Ball, S.W., Monuteaux, M.C., Surman, C.B., Johnson, J.L., Zeitlin, S. (2007). Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study.
J. Dev. Behav. Pediatr., 28(4), 302-307.
[
http://dx.doi.org/10.1097/DBP.0b013e3180327917] [PMID:
17700082]
Bloch, M.H., Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis.
J. Am. Acad. Child Adolesc. Psychiatry, 50(10), 991-1000.
[
http://dx.doi.org/10.1016/j.jaac.2011.06.008] [PMID:
21961774]
Bolea-Alamañac, B., Nutt, D.J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., Sayal, K., Sonuga-Barke, E., Young, S.J. (2014). Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology.
J. Psychopharmacol., 28(3), 179-203.
[
http://dx.doi.org/10.1177/0269881113519509] [PMID:
24526134]
Braeckman, R., Guenther, S., Mickle, T.C., Barrett, A.C., Smith, A., Oh, C. (2022). Dose proportionality and steady-state pharmacokinetics of serdexmethylphenidate/dexmethylphenidate, a novel prodrug combination to treat attention-deficit/hyperactivity disorder.
J. Child Adolesc. Psychopharmacol., 32(5), 288-295.
[
http://dx.doi.org/10.1089/cap.2022.0015] [PMID:
35666231]
Bragazzi, N.L., Briki, W., Khabbache, H., Rammouz, I., Mnadla, S., Demaj, T., Zouhir, M. (2015). Ramadan fasting and infectious diseases: A systematic review.
J. Infect. Dev. Ctries., 9(11), 1186-1194.
[
http://dx.doi.org/10.3855/jidc.5815] [PMID:
26623627]
Bushe, C.J., Savill, N.C. (2014). Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009–2011: Focus on clinical efficacy and safety.
J. Psychopharmacol., 28(3), 204-211.
[
http://dx.doi.org/10.1177/0269881113478475] [PMID:
23438503]
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M.J., Ridao, M., Macías Saint-Gerons, D., Catalá, M.A., Tabarés-Seisdedos, R., Moher, D. (2017). The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
PLoS One, 12(7), e0180355.
[
http://dx.doi.org/10.1371/journal.pone.0180355] [PMID:
28700715]
Coghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R.W., Doepfner, M., Ferrin, M., Hollis, C., Holtmann, M., Paramala, S., Sonuga-Barke, E., Soutullo, C., Steinhausen, H.C., Van der Oord, S., Wong, I.C.K., Zuddas, A., Simonoff, E. (2023). The management of ADHD in children and adolescents: Bringing evidence to the clinic: Perspective from the European ADHD Guidelines Group (EAGG).
Eur. Child Adolesc. Psychiatry, 32(8), 1337-1361.
[
http://dx.doi.org/10.1007/s00787-021-01871-x] [PMID:
34677682]
Cohen, A., Asraf, K., Saveliev, I., Dan, O., Haimov, I. (2021). The effects of sleep deprivation on the processing of emotional facial expressions in young adults with and without ADHD.
Sci. Rep., 11(1), 14241.
[
http://dx.doi.org/10.1038/s41598-021-93641-7] [PMID:
34244583]
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A.J., Carucci, S., Atkinson, L.Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.C., Shokraneh, F., Xia, J., Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis.
Lancet Psychiatry, 5(9), 727-738.
[
http://dx.doi.org/10.1016/S2215-0366(18)30269-4] [PMID:
30097390]
Cruz, J.P., Colet, P.C., Alquwez, N., Inocian, E.P., Al-Otaibi, R.S., Islam, S.M.S. (2017). Influence of religiosity and spiritual coping on health‐related quality of life in Saudi haemodialysis patients.
Hemodial. Int., 21(1), 125-132.
[
http://dx.doi.org/10.1111/hdi.12441] [PMID:
27329681]
Donnelly, G., Rodriguez, R., Cataldo, M., Bhaskar, S. (2021). 5. 8 comparison of adhansia xr and concerta pharmacokinetic profiles.
J. Am. Acad. Child Adolesc. Psychiatry, 60(10), S152.
[
http://dx.doi.org/10.1016/j.jaac.2021.09.056]
Eddahby, S., Kadri, N., Moussaoui, D. (2014). Fasting during Ramadan is associated with a higher recurrence rate in patients with bipolar disorder.
World Psychiatry, 13(1), 97.
[
http://dx.doi.org/10.1002/wps.20113] [PMID:
24497261]
Elnadry, M.H., Nigm, I.A., Abdel Aziz, I.M., Elshafee, A.M., Elazhary, S.S., Abdel Hafeez, M.A., Mohii, S.M., Elteeby, D.M. (2011). Effect of Ramadan fasting on Muslim patients with chronic liver diseases.
J. Egypt. Soc. Parasitol., 41(2), 337-346.
[PMID:
21980772]
Emara, M.H., Soliman, H.H., Elnadry, M., Mohamed Said, E., Abd-Elsalam, S., Elbatae, H.E., Zaher, T.I., Ezzeldin, S., Bazeed, S., Abdel-Razik, A., Youssef Mohamed, S., Elfert, A. (2021). Ramadan fasting and liver diseases: A review with practice advices and recommendations.
Liver Int., 41(3), 436-448.
[
http://dx.doi.org/10.1111/liv.14775] [PMID:
33369880]
Faraone, S.V. (2018). The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
Neurosci. Biobehav. Rev., 87, 255-270.
[
http://dx.doi.org/10.1016/j.neubiorev.2018.02.001] [PMID:
29428394]
Faraone, S.V., Sergeant, J., Gillberg, C., Biederman, J. (2003). The worldwide prevalence of ADHD: Is it an American condition?
World Psychiatry, 2(2), 104-113.
[PMID:
16946911]
Farooq, A., Herrera, C.P., Almudahka, F., Mansour, R. (2015). A prospective study of the physiological and neurobehavioral effects of ramadan fasting in preteen and teenage boys.
J. Acad. Nutr. Diet., 115(6), 889-897.
[
http://dx.doi.org/10.1016/j.jand.2015.02.012] [PMID:
25840939]
Fernando, H., Zibellini, J., Harris, R., Seimon, R., Sainsbury, A. (2019). Effect of ramadan fasting on weight and body composition in healthy non-athlete adults: A systematic review and meta-analysis.
Nutrients, 11(2), 478.
[
http://dx.doi.org/10.3390/nu11020478] [PMID:
30813495]
Furqan, Z., Awaad, R., Kurdyak, P., Husain, M.I., Husain, N., Zaheer, J. (2019). Considerations for clinicians treating Muslim patients with psychiatric disorders during Ramadan.
Lancet Psychiatry, 6(7), 556-557.
[
http://dx.doi.org/10.1016/S2215-0366(19)30161-0] [PMID:
31056458]
Hassanein, M., Afandi, B., Yakoob Ahmedani, M., Mohammad Alamoudi, R., Alawadi, F., Bajaj, H.S., Basit, A., Bennakhi, A., El Sayed, A.A., Hamdy, O., Hanif, W., Jabbar, A., Kleinebreil, L., Lessan, N., Shaltout, I., Mohamad Wan Bebakar, W., Abdelgadir, E., Abdo, S., Al Ozairi, E., Al Saleh, Y., Alarouj, M., Ali, T., Ali Almadani, A., Helmy Assaad-Khalil, S., Bashier, A.M.K., Arifi Beshyah, S., Buyukbese, M.A., Ahmad Chowdhury, T., Norou Diop, S., Samir Elbarbary, N., Elhadd, T.A., Eliana, F., Ezzat Faris, M., Hafidh, K., Hussein, Z., Iraqi, H., Kaplan, W., Khan, T.S., Khunti, K., Maher, S., Malek, R., Malik, R.A., Mohamed, M., Sayed Kamel Mohamed, M., Ahmed Mohamed, N., Pathan, S., Rashid, F., Sahay, R.K., Taha Salih, B., Sandid, M.A., Shaikh, S., Slim, I., Tayeb, K., Mohd Yusof, B.N., Binte Zainudin, S. (2022). Diabetes and Ramadan: Practical guidelines 2021.
Diabetes Res. Clin. Pract., 185, 109185.
[
http://dx.doi.org/10.1016/j.diabres.2021.109185] [PMID:
35016991]
Hemamy, M., Pahlavani, N., Amanollahi, A., Islam, S.M.S., McVicar, J., Askari, G., Malekahmadi, M. (2021). The effect of vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: A randomized controlled trial.
BMC Pediatr., 21(1), 178.
[
http://dx.doi.org/10.1186/s12887-021-02631-1] [PMID:
33865361]
Heun, R. (2018). A systematic review on the effect of Ramadan on mental health: Minor effects and no harm in general, but increased risk of relapse in schizophrenia and bipolar disorder.
Glob. Psychiatry, 1(1), 7-16.
[
http://dx.doi.org/10.2478/gp-2018-0002]
Ilic, K., Kugler, A.R., Yan, B., McNamara, N. (2022). Pharmacokinetics, safety, and tolerability of shp465 mixed amphetamine salts after administration of multiple daily doses in children aged 4–5 years with attention-deficit/hyperactivity disorder.
CNS Drugs, 36(1), 71-81.
[
http://dx.doi.org/10.1007/s40263-021-00870-5] [PMID:
34826114]
Jahrami, H.A., Alsibai, J., Clark, C.C.T., Faris, M.A.I.E. (2020). A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above.
Eur. J. Nutr., 59(6), 2291-2316.
[
http://dx.doi.org/10.1007/s00394-020-02216-1] [PMID:
32157368]
Jornay, P.M. (2019). Jornay PM -- evening-dosed methylphenidate for ADHD.
Med. Lett. Drugs Ther., 61(1578), 126-128.
[PMID:
31386648]
Kalra, S., Al Deeb, A., Sahay, R. (2019). Ramadan fasting in children.
J. Pak. Med. Assoc., 69(5), 745-746.
[PMID:
31105303]
Kollins, S.H., Jain, R., Brams, M., Segal, S., Findling, R.L., Wigal, S.B., Khayrallah, M. (2011). Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
Pediatrics, 127(6), e1406-e1413.
[
http://dx.doi.org/10.1542/peds.2010-1260] [PMID:
21555501]
Koushali, A.N., Hajiamini, Z., Ebadi, A., Bayat, N., Khamseh, F. (2013). Effect of Ramadan fasting on emotional reactions in nurses.
Iran. J. Nurs. Midwifery Res., 18(3), 232-236.
[PMID:
23983761]
Kretchy, I., Owusu-Daaku, F., Danquah, S. (2013). Spiritual and religious beliefs: Do they matter in the medication adherence behaviour of hypertensive patients?
Biopsychosoc. Med., 7(1), 15.
[
http://dx.doi.org/10.1186/1751-0759-7-15] [PMID:
24138844]
Kul, S., Savaş, E., Öztürk, Z.A., Karadağ, G. (2014). Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis.
J. Relig. Health, 53(3), 929-942.
[
http://dx.doi.org/10.1007/s10943-013-9687-0] [PMID:
23423818]
Larson, K., Russ, S.A., Kahn, R.S., Halfon, N. (2011). Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007.
Pediatrics, 127(3), 462-470.
[
http://dx.doi.org/10.1542/peds.2010-0165] [PMID:
21300675]
Maneeton, B., Maneeton, N., Suttajit, S., Reungyos, J., Srisurapanont, M., Martin, S. (2014). Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD.
Drug Des. Devel. Ther., 8, 1685-1693.
[
http://dx.doi.org/10.2147/DDDT.S68393] [PMID:
25336914]
Markowitz, J.S., Straughn, A.B., Patrick, K.S., DeVane, C.L., Pestreich, L., Lee, J., Wang, Y., Muniz, R. (2003). Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Clin. Pharmacokinet., 42(4), 393-401.
[
http://dx.doi.org/10.2165/00003088-200342040-00007] [PMID:
12648029]
Martinez-Raga, J., Ferreros, A., Knecht, C., de Alvaro, R., Carabal, E. (2017). Attention-deficit hyperactivity disorder medication use: Factors involved in prescribing, safety aspects and outcomes.
Ther. Adv. Drug Saf., 8(3), 87-99.
[
http://dx.doi.org/10.1177/2042098616679636] [PMID:
28382197]
Mayer, J.S., Brandt, G.A., Medda, J., Basten, U., Grimm, O., Reif, A., Freitag, C.M. (2022). Depressive symptoms in youth with ADHD: The role of impairments in cognitive emotion regulation.
Eur. Arch. Psychiatry Clin. Neurosci., 272(5), 793-806.
[
http://dx.doi.org/10.1007/s00406-022-01382-z] [PMID:
35107603]
MTA Cooperative Group. (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.
Pediatrics, 113(4), 754-761.
[
http://dx.doi.org/10.1542/peds.113.4.754] [PMID:
15060224]
Muammar, T., Fojas, E.G.F., Helal, R., Lessan, N. (2022). Ramadan fasting among older children and adolescents with type 1 diabetes mellitus: A real-world study from the uae.
Front. Nutr., 9, 786678.
[
http://dx.doi.org/10.3389/fnut.2022.786678] [PMID:
35399686]
Nasser, A., Liranso, T., Adewole, T., Fry, N., Hull, J.T., Chowdhry, F., Busse, G.D., Cutler, A.J., Jones, N.J., Findling, R.L., Schwabe, S. (2020). A phase III, randomized, placebo-controlled trial to assess the efficacy and safety of once-daily spn-812 (Viloxazine Extended-release) in the treatment of attention-deficit/hyperactivity disorder in school-age children.
Clin. Ther., 42(8), 1452-1466.
[
http://dx.doi.org/10.1016/j.clinthera.2020.05.021] [PMID:
32723670]
Newcorn, J.H., Stark, J.G., Adcock, S., McMahen, R., Sikes, C. (2017). A randomized phase I study to assess the effect of alcohol on the pharmacokinetics of an extended-release orally disintegrating tablet formulation of amphetamine in healthy adults.
Clin. Ther., 39(8), 1695-1705.
[
http://dx.doi.org/10.1016/j.clinthera.2017.07.006] [PMID:
28760535]
Palumbo, D.R., Sallee, F.R., Pelham, W., Jr, Bukstein, O.G., Daviss, W.B. McDERMOTT, M.P.. (2008). Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
J. Am. Acad. Child Adolesc. Psychiatry, 47(2), 180-188.
[
http://dx.doi.org/10.1097/chi.0b013e31815d9af7] [PMID:
18182963]
Pathy, R., Mills, K.E., Gazeley, S., Ridgley, A., Kiran, T. (2011). Health is a spiritual thing: Perspectives of health care professionals and female Somali and Bangladeshi women on the health impacts of fasting during Ramadan.
Ethn. Health, 16(1), 43-56.
[
http://dx.doi.org/10.1080/13557858.2010.523780] [PMID:
21170771]
Polanczyk, G.V., Willcutt, E.G., Salum, G.A., Kieling, C., Rohde, L.A. (2014). ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis.
Int. J. Epidemiol., 43(2), 434-442.
[
http://dx.doi.org/10.1093/ije/dyt261] [PMID:
24464188]
Roesch, B., Corcoran, M., Haffey, M., Stevenson, A., Wang, P., Purkayastha, J., Martin, P., Ermer, J. (2013). Pharmacokinetics of coadministration of guanfacine extended release and methylphenidate extended release.
Drugs R D., 13(1), 53-61.
[
http://dx.doi.org/10.1007/s40268-013-0009-5] [PMID:
23519656]
Roky, R., Chapotot, F., Hakkou, F., Benchekroun, M.T., Buguet, A. (2001). Sleep during Ramadan intermittent fasting.
J. Sleep Res., 10(4), 319-327.
[
http://dx.doi.org/10.1046/j.1365-2869.2001.00269.x] [PMID:
11903862]
Ruiz-Goikoetxea, M., Cortese, S., Aznarez-Sanado, M., Magallón, S., Alvarez Zallo, N., Luis, E.O., de Castro-Manglano, P., Soutullo, C., Arrondo, G. (2018). Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis.
Neurosci. Biobehav. Rev., 84, 63-71.
[
http://dx.doi.org/10.1016/j.neubiorev.2017.11.007] [PMID:
29162520]
Sadeghirad, B., Motaghipisheh, S., Kolahdooz, F., Zahedi, M.J., Haghdoost, A.A. (2014). Islamic fasting and weight loss: A systematic review and meta-analysis.
Public Health Nutr., 17(2), 396-406.
[
http://dx.doi.org/10.1017/S1368980012005046] [PMID:
23182306]
Saletin, J.M., Jackvony, S., Rodriguez, K.A., Dickstein, D.P. (2019). A coordinate-based meta-analysis comparing brain activation between attention deficit hyperactivity disorder and total sleep deprivation.
Sleep, 42(3), zsy251.
[
http://dx.doi.org/10.1093/sleep/zsy251] [PMID:
30541103]
Sallee, F.R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., Biederman, J. (2009). Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: A placebo-controlled trial.
J. Am. Acad. Child Adolesc. Psychiatry, 48(2), 155-165.
[
http://dx.doi.org/10.1097/CHI.0b013e318191769e] [PMID:
19106767]
Salti, I., Bénard, E., Detournay, B., Bianchi-Biscay, M., Le Brigand, C., Voinet, C., Jabbar, A. (2004). A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
Diabetes Care, 27(10), 2306-2311.
[
http://dx.doi.org/10.2337/diacare.27.10.2306] [PMID:
15451892]
Shaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A.G., Arnold, L.E. (2012). A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: Effects of treatment and non-treatment.
BMC Med., 10(1), 99.
[
http://dx.doi.org/10.1186/1741-7015-10-99] [PMID:
22947230]
Steingard, R., Taskiran, S., Connor, D.F., Markowitz, J.S., Stein, M.A. (2019). New formulations of stimulants: An update for clinicians.
J. Child Adolesc. Psychopharmacol., 29(5), 324-339.
[
http://dx.doi.org/10.1089/cap.2019.0043] [PMID:
31038360]
Storebø, O.J., Elmose Andersen, M., Skoog, M., Joost Hansen, S., Simonsen, E., Pedersen, N., Tendal, B., Callesen, H.E., Faltinsen, E., Gluud, C. (2019). Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.
Cochrane Libr., 2019(6), CD008223.
[
http://dx.doi.org/10.1002/14651858.CD008223.pub3] [PMID:
31222721]
Swanson, J.M. (2005). Long-acting stimulants: Development and dosing.
Can. Child Adolesc. Psychiatr. Rev., 14 (Suppl. 1), 4-9.
[PMID:
19030518]
(a)Teo, S.K., Scheffler, M.R., Wu, A., Stirling, D.I., Thomas, S.D., Stypinski, D., Khetani, V.D. (2004). A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.
J. Clin. Pharmacol., 44(2), 173-178.
[
http://dx.doi.org/10.1177/0091270003261899] [PMID:
14747426]
(b)Wolraich, M.L., Hagan, J.F., Jr, Allan, C., Chan, E., Davison, D., Earls, M., Evans, S.W., Flinn, S.K., Froehlich, T., Frost, J., Holbrook, J.R., Lehmann, C.U., Lessin, H.R., Okechukwu, K., Pierce, K.L., Winner, J.D., Zurhellen, W. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
Pediatrics, 144(4), e20192528.
[
http://dx.doi.org/10.1542/peds.2019-2528] [PMID:
31570648]
